Cellium, our first New Botanical Entity, stands on
a novel, patented, 3-level mechanism of action
Increased resistance to apoptosis1,2
Cellium restores (before 3 months) number of cells expressing Bcl-2 in AGA subjects to levels close to those observed in healthy controls.
It promotes significantly (+74%) Langherans cells in epidermis, which modulate immune response and exercise anti-inflammatory functions.
Collagen content and remodeling3
Collagen around the follicle increased by 79,93% within 4 months after application start. Collagen fibers are thicker and remodeled.